Mergers & Acquisitions Mergers & Acquisitions

Public officials to blame for outsized power of prescription drug middlemen, US FTC’s Khan says

By Michael Acton
  • 22 Jun 2022 20:19
  • 22 Jun 2022 20:19
Consumers suffering from higher prescription drug costs due to powerful middlemen who sit between drug manufacturers and pharmacies can blame years of bad decisions by public officials, US Federal Trade Commission Chair Lina Khan said today.
“All of these features of our current system are the result of policy choices

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Michael Acton

Senior Correspondent


Michael is a senior correspondent for MLex in San Francisco, where he moved in 2020 after working in our Brussels bureau. Before joining MLex, he reported on EU politics as the Financial Times’ Nico Colchester Fellow in Brussels. Michael has a degree in International Relations and Politics from the University of Cambridge, and a degree in History and French from University College London and Paris IV Sorbonne.

Discover MLex

Stay on top of global regulatory developments

Latest News